FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099122425> ?p ?o ?g. }

• W2099122425 endingPage "846" @default.
• W2099122425 startingPage "840" @default.
• W2099122425 abstract "Abstract Purpose: Epidermal growth factor (EGF) might be a suitable immunotherapeutic target in non–small-cell lung cancer (NSCLC). Our approach consists of active immunotherapy with EGF. The aim of the study is to characterize the humoral response and its effects on signal transduction in relation with the clinical outcome. Experimental Design: Eighty NSCLC patients treated with first-line chemotherapy were randomized to receive the EGF vaccine or supportive care. EGF concentration in sera, anti-EGF antibodies and their capacity to inhibit the binding between EGF/EGF receptor (EGFR), and the EGFR phosphorylation were measured. Results: Seventy-three percent of vaccinated patients developed a good antibody response, whereas none of the controls did. In good antibody-responder patients, self EGF in sera was significantly reduced. In 58% of vaccinated patients, the post-immune sera inhibited EGF/EGFR binding; in the control group, no inhibition occurred. Post-immune sera inhibited the EGFR phosphorylation whereas sera from control patients did not have this capacity. Good antibody-responder patients younger than 60 years had a significantly better survival. A high correlation between anti-EGF antibody titers, EGFR phosphorylation inhibition, and EGF/EGFR binding inhibition was found. There was a significantly better survival for vaccinated patients that showed the higher capacity to inhibit EGF/EGFR binding and for those who showed an immunodominance by the central region of EGF molecule. Conclusions: Immunization with the EGF vaccine induced neutralizing anti-EGF antibodies capable of inhibiting EGFR phosphorylation. There was a significant positive correlation between antibody titers, EGF/EGFR binding inhibition, immunodominance of anti-EGF antibodies, and survival in advanced NSCLC patients." @default.
• W2099122425 created "2016-06-24" @default.
• W2099122425 creator A5002029328 @default.
• W2099122425 creator A5006318317 @default.
• W2099122425 creator A5010072218 @default.
• W2099122425 creator A5022492026 @default.
• W2099122425 creator A5042963282 @default.
• W2099122425 creator A5067005493 @default.
• W2099122425 creator A5067739096 @default.
• W2099122425 creator A5070534105 @default.
• W2099122425 creator A5082455874 @default.
• W2099122425 creator A5091661570 @default.
• W2099122425 date "2008-02-01" @default.
• W2099122425 modified "2023-10-03" @default.
• W2099122425 title "Effective Inhibition of the Epidermal Growth Factor/Epidermal Growth Factor Receptor Binding by Anti–Epidermal Growth Factor Antibodies Is Related to Better Survival in Advanced Non–Small-Cell Lung Cancer Patients Treated with the Epidermal Growth Factor Cancer Vaccine" @default.
• W2099122425 cites W1504944877 @default.
• W2099122425 cites W1512900561 @default.
• W2099122425 cites W1578803305 @default.
• W2099122425 cites W1986727868 @default.
• W2099122425 cites W1995684830 @default.
• W2099122425 cites W2002339959 @default.
• W2099122425 cites W2023423199 @default.
• W2099122425 cites W2024992753 @default.
• W2099122425 cites W2034309045 @default.
• W2099122425 cites W2049221918 @default.
• W2099122425 cites W2051120695 @default.
• W2099122425 cites W2052595539 @default.
• W2099122425 cites W2056436868 @default.
• W2099122425 cites W2064047613 @default.
• W2099122425 cites W2072031500 @default.
• W2099122425 cites W2076687153 @default.
• W2099122425 cites W2078342447 @default.
• W2099122425 cites W2138216710 @default.
• W2099122425 cites W2144641242 @default.
• W2099122425 cites W2145751474 @default.
• W2099122425 cites W2155741470 @default.
• W2099122425 cites W2167368130 @default.
• W2099122425 cites W2171190459 @default.
• W2099122425 doi "https://doi.org/10.1158/1078-0432.ccr-07-1050" @default.
• W2099122425 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18245547" @default.
• W2099122425 hasPublicationYear "2008" @default.
• W2099122425 type Work @default.
• W2099122425 sameAs 2099122425 @default.
• W2099122425 citedByCount "109" @default.
• W2099122425 countsByYear W20991224252012 @default.
• W2099122425 countsByYear W20991224252013 @default.
• W2099122425 countsByYear W20991224252014 @default.
• W2099122425 countsByYear W20991224252015 @default.
• W2099122425 countsByYear W20991224252016 @default.
• W2099122425 countsByYear W20991224252017 @default.
• W2099122425 countsByYear W20991224252018 @default.
• W2099122425 countsByYear W20991224252019 @default.
• W2099122425 countsByYear W20991224252020 @default.
• W2099122425 countsByYear W20991224252021 @default.
• W2099122425 countsByYear W20991224252022 @default.
• W2099122425 countsByYear W20991224252023 @default.
• W2099122425 crossrefType "journal-article" @default.
• W2099122425 hasAuthorship W2099122425A5002029328 @default.
• W2099122425 hasAuthorship W2099122425A5006318317 @default.
• W2099122425 hasAuthorship W2099122425A5010072218 @default.
• W2099122425 hasAuthorship W2099122425A5022492026 @default.
• W2099122425 hasAuthorship W2099122425A5042963282 @default.
• W2099122425 hasAuthorship W2099122425A5067005493 @default.
• W2099122425 hasAuthorship W2099122425A5067739096 @default.
• W2099122425 hasAuthorship W2099122425A5070534105 @default.
• W2099122425 hasAuthorship W2099122425A5082455874 @default.
• W2099122425 hasAuthorship W2099122425A5091661570 @default.
• W2099122425 hasBestOaLocation W20991224251 @default.
• W2099122425 hasConcept C121608353 @default.
• W2099122425 hasConcept C126322002 @default.
• W2099122425 hasConcept C159654299 @default.
• W2099122425 hasConcept C170493617 @default.
• W2099122425 hasConcept C195616568 @default.
• W2099122425 hasConcept C203014093 @default.
• W2099122425 hasConcept C2776256026 @default.
• W2099122425 hasConcept C2776362946 @default.
• W2099122425 hasConcept C2776525413 @default.
• W2099122425 hasConcept C2777701055 @default.
• W2099122425 hasConcept C2779438470 @default.
• W2099122425 hasConcept C502942594 @default.
• W2099122425 hasConcept C71924100 @default.
• W2099122425 hasConcept C86803240 @default.
• W2099122425 hasConcept C8891405 @default.
• W2099122425 hasConceptScore W2099122425C121608353 @default.
• W2099122425 hasConceptScore W2099122425C126322002 @default.
• W2099122425 hasConceptScore W2099122425C159654299 @default.
• W2099122425 hasConceptScore W2099122425C170493617 @default.
• W2099122425 hasConceptScore W2099122425C195616568 @default.
• W2099122425 hasConceptScore W2099122425C203014093 @default.
• W2099122425 hasConceptScore W2099122425C2776256026 @default.
• W2099122425 hasConceptScore W2099122425C2776362946 @default.
• W2099122425 hasConceptScore W2099122425C2776525413 @default.
• W2099122425 hasConceptScore W2099122425C2777701055 @default.
• W2099122425 hasConceptScore W2099122425C2779438470 @default.
• W2099122425 hasConceptScore W2099122425C502942594 @default.
• W2099122425 hasConceptScore W2099122425C71924100 @default.
• W2099122425 hasConceptScore W2099122425C86803240 @default.
• W2099122425 hasConceptScore W2099122425C8891405 @default.

• next